Benedetti & Gucer, Inc. Viatris Inc Transaction History
Benedetti & Gucer, Inc.
- $201 Million
- Q1 2024
A detailed history of Benedetti & Gucer, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Benedetti & Gucer, Inc. holds 51,229 shares of VTRS stock, worth $528,683. This represents 0.3% of its overall portfolio holdings.
Number of Shares
51,229
Previous 51,933
1.36%
Holding current value
$528,683
Previous $562,000
8.9%
% of portfolio
0.3%
Previous 0.3%
Shares
5 transactions
Others Institutions Holding VTRS
# of Institutions
1,101Shares Held
945MCall Options Held
3.49MPut Options Held
2.6M-
Vanguard Group Inc Valley Forge, PA142MShares$1.46 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY93.3MShares$963 Million0.03% of portfolio
-
State Street Corp Boston, MA62.8MShares$648 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD57.9MShares$597 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$593 Million3.85% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.5B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...